» Articles » PMID: 32534153

Significance of Host Heparanase in Promoting Tumor Growth and Metastasis

Overview
Journal Matrix Biol
Publisher Elsevier
Date 2020 Jun 14
PMID 32534153
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Heparanase, the sole heparan sulfate degrading endoglycosidase, regulates multiple biological activities that enhance tumor growth, angiogenesis and metastasis. Much of the impact of heparanase on tumor progression is related to its function in mediating tumor-host crosstalk, priming the tumor microenvironment to better support tumor growth and metastasis. We have utilized mice over-expressing (Hpa-tg) heparanase to reveal the role of host heparanase in tumor initiation, growth and metastasis. While in wild type mice tumor development in response to DMBA carcinogenesis was restricted to the mammary gland, Hpa-tg mice developed tumors also in their lungs and liver, associating with reduced survival of the tumor-bearing mice. Consistently, xenograft tumors (lymphoma, melanoma, lung carcinoma, pancreatic carcinoma) transplanted in Hpa-tg mice exhibited accelerated tumor growth and shorter survival of the tumor-bearing mice compared with wild type mice. Hpa-tg mice were also more prone to the development of metastases following intravenous or subcutaneous injection of tumor cells. In some models, the growth advantage was associated with infiltration of heparanase-high host cells into the tumors. However, in other models, heparanase-high host cells were not detected in the primary tumor, implying that the growth advantage in Hpa-tg mice is due to systemic factors. Indeed, we found that plasma from Hpa-tg mice enhanced tumor cell migration and invasion attributed to increased levels of pro-tumorigenic factors (i.e., RANKL, SPARC, MIP-2) in the plasma of Hpa-Tg vs. wild type mice. Furthermore, tumor aggressiveness and short survival time were demonstrated in wild type mice transplanted with bone marrow derived from Hpa-tg but not wild type mice. These results were attributed, among other factors, to upregulation of pro-tumorigenic (i.e., IL35) and downregulation of anti-tumorigenic (i.e., IFN-γ) T-cell subpopulations in the spleen, lymph nodes and blood of Hpa-tg vs. wild type mice and their increased infiltration into the primary tumor. Collectively, our results emphasize the significance of host heparanase in mediating the pro-tumorigenic and pro-metastatic interactions between the tumor cells and the host tumor microenvironment, immune cells and systemic factors.

Citing Articles

Quantitative proteomics and multi-omics analysis identifies potential biomarkers and the underlying pathological molecular networks in Chinese patients with multiple sclerosis.

Yang F, Zhao L, Yang W, Chao S, Ling Z, Sun B BMC Neurol. 2024; 24(1):423.

PMID: 39478468 PMC: 11526627. DOI: 10.1186/s12883-024-03926-3.


The landscape of circRNAs in gliomas temozolomide resistance: Insights into molecular pathways.

Mafi A, Hedayati N, Kahkesh S, Khoshayand S, Alimohammadi M, Farahani N Noncoding RNA Res. 2024; 9(4):1178-1189.

PMID: 39022676 PMC: 11250881. DOI: 10.1016/j.ncrna.2024.05.010.


Role of a Novel Heparanase Inhibitor on the Balance between Apoptosis and Autophagy in U87 Human Glioblastoma Cells.

Manganelli V, Misasi R, Riitano G, Capozzi A, Mattei V, Caglar T Cells. 2023; 12(14).

PMID: 37508554 PMC: 10378526. DOI: 10.3390/cells12141891.


Heparanase 2 (Hpa2)- a new player essential for pancreatic acinar cell differentiation.

Kayal Y, Barash U, Naroditsky I, Ilan N, Vlodavsky I Cell Death Dis. 2023; 14(7):465.

PMID: 37491420 PMC: 10368643. DOI: 10.1038/s41419-023-05990-y.


Effect of HPSE and HPSE2 SNPs on the Risk of Developing Primary Paraskeletal Multiple Myeloma.

Ostrovsky O, Beider K, Magen H, Leiba M, Sanderson R, Vlodavsky I Cells. 2023; 12(6).

PMID: 36980254 PMC: 10047783. DOI: 10.3390/cells12060913.


References
1.
Karamanos N, Theocharis A, Neill T, Iozzo R . Matrix modeling and remodeling: A biological interplay regulating tissue homeostasis and diseases. Matrix Biol. 2018; 75-76:1-11. PMC: 6377817. DOI: 10.1016/j.matbio.2018.08.007. View

2.
Hammond E, Khurana A, Shridhar V, Dredge K . The Role of Heparanase and Sulfatases in the Modification of Heparan Sulfate Proteoglycans within the Tumor Microenvironment and Opportunities for Novel Cancer Therapeutics. Front Oncol. 2014; 4:195. PMC: 4109498. DOI: 10.3389/fonc.2014.00195. View

3.
Gaskin S, Soares da Costa T, Hulett M . Heparanase: Cloning, Function and Regulation. Adv Exp Med Biol. 2020; 1221:189-229. DOI: 10.1007/978-3-030-34521-1_7. View

4.
Yamauchi M, Gibbons D, Zong C, Fradette J, Bota-Rabassedas N, Kurie J . Fibroblast heterogeneity and its impact on extracellular matrix and immune landscape remodeling in cancer. Matrix Biol. 2020; 91-92:8-18. DOI: 10.1016/j.matbio.2020.05.001. View

5.
Menten P, Saccani A, Dillen C, Wuyts A, Struyf S, Proost P . Role of the autocrine chemokines MIP-1alpha and MIP-1beta in the metastatic behavior of murine T cell lymphoma. J Leukoc Biol. 2002; 72(4):780-9. View